Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances
The incidence of hepatocellular carcinoma (HCC) ranks first among primary liver cancers, and its mortality rate exhibits a consistent annual increase. The treatment of HCC has witnessed a significant surge in recent years, with the emergence of targeted immune therapy as an adjunct to early surgical...
Main Authors: | Xiang Wang, Zijun Yuan, Zhengbo Li, Xinyu He, Yinping Zhang, Xingyue Wang, Jiahong Su, Xu Wu, Mingxing Li, Fukuan Du, Yu Chen, Shuai Deng, Yueshui Zhao, Jing Shen, Tao Yi, Zhangang Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1354313/full |
Similar Items
-
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
by: Yueshui Zhao, et al.
Published: (2022-08-01) -
Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
by: Qingfan Yang, et al.
Published: (2022-01-01) -
Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma
by: Fang Wang, et al.
Published: (2022-10-01) -
Therapeutic prospects of ceRNAs in COVID-19
by: Lin Liu, et al.
Published: (2022-09-01) -
Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities
by: Liyao Tang, et al.
Published: (2023-02-01)